Complete axillary conversion after neoadjuvant chemotherapy in locally advanced breast cancer: A step towards conserving axilla?

Indian Journal of Cancer

Volumn 41, Issue 1, 2004, Pages 13-17

  Arimappamagan, A ^a   Kadambari, D ^a   Srinivasan, K ^a   Krishnan, R ^a   Elangovan, S ^a   Reddy, K S N ^a  

^a Department of General Surgery ^*

Author keywords

Axillary nodal response; Locally advanced breast cancer; Neoadjuvant chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AXILLA; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; MEDICAL DOCUMENTATION; SENSITIVITY ANALYSIS;

ANALYSIS OF VARIANCE; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY, SIMPLE; MIDDLE AGED; NEOADJUVANT THERAPY; REMISSION INDUCTION; STATISTICS, NONPARAMETRIC; VINCRISTINE;

EID: 2442498639     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Singletary E. Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer. Am J Surg 2001;182:341-6.
2. Julian TB, Patel N, Dusi D, Olson P, Nathan G, Jasnosz K, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001;182:407-10.
3. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 1999;230:72-8.
4. Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin based neoadjuvant chemotherapy. J Clin Oncol 1999;17:460-9.
5. McCready DR, Hortobagyi GN, Kau SW, Smith TL, Buzdar AU, Balch CM. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 1989;124:21-5.
6. Vlastos G , Fornage BD, Mirza NQ, Bedi D, Lenert JT, Winchester DJ et al. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg 2000;179:446-452.
7. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of Cancer treatment. Cancer 1981;47:207-14.
8. Herrada J, Iyer RB, Atkinson EN, Sneige N, Buzdar AU, Hortobagyi GN. Relative value of physical examination, mammography and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Can Res 1997;3:1565-9.
9. Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, et al. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol 1998;5:673-80.
10. Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL. Axillary lymph node metastases in breast cancer: pre-operative detection with ultrasound. Radiology 1986;158:325-6.
11. Tate JJ, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1989;15:139-41.
12. Pamilo M, Soiva M, Lavast EM. Real time ultrasound, axillary mammography and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med 1989;8:115-20.
13. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483-93.
14. Gianni L, Valagussa P, Zambetti M, Moliterni A, Capri G, Bonadonna G. Adjuvant and neoadjuvant treatment of breast cancer. Semin Oncol 2001;28:13-29.
15. Emilia L, Dauway, Rosemary Giuliano, Fadi Haddad, et al. Lymphatic mapping in breast cancer. Hematol/Oncol Clin N Am 1999;13:349-70.
16. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, et al. Relation of the number of positive axillary nodes to the prognosis of patients with primary breast cancer, an NSABP update. Cancer 1983;52:1551-7.
17. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-20.
18. Werner RS, McCormick B, Petrek J, Cox L, Cirrincione C, Gray JR, et al. Arm edema in conservatively managed breast cancer: Obesity is a major predictive factor. Radiology 1991;180:177-84.
19. Bruce J. Operable cancer of the breast: a controlled clinical trial. Cancer 1971;18:1443-53.
20. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674-81.
21. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
22. Reitsamer B, Peintinger F, Rettenbacher L, Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 2003;84:63-7.
23. Schwartz GF, Meltzer AJ. Accuracy of axillary sentinel lymph node biopsy following neodjuvant chemotherapy for carcinomabreast. Breast J 2003;9:374-9.
24. Sabel MS, Schott AF, Kleer CG, Merajver S, Cimmino VM, Diehl KM, et al. Sentinel node biopsy prior to neoadjuvant chemo-therapy. Am J Surg 2003;186:102-5.